TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Aros Forskning & Friskvård AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
404
|
302
|
191 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
619
|
244
|
97 |
| EBITDA |
252
|
244
|
97 |
| Total assets |
937
|
760
|
593 |
| Current assets |
61
|
213
|
112 |
| Current liabilities |
100
|
74
|
36 |
| Equity capital |
837
|
677
|
548 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
89.3%
|
89.1%
|
92.4% |
| Turnover per employee |
404
|
302
|
191 |
| Profit as a percentage of turnover |
153.2%
|
80.8%
|
50.8% |
| Return on assets (ROA) |
66.1%
|
32.1%
|
16.4% |
| Current ratio |
61.0%
|
287.8%
|
311.1% |
| Return on equity (ROE) |
74.0%
|
36.0%
|
17.7% |
| Change turnover |
102
|
111
|
-53 |
| Change turnover % |
34%
|
58%
|
-22% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.